ACLX Arcellx, Inc.

HealthcareBiotechnology
$115.07
▲ 0.00%
30
QScore Signal
Short
Confidence: MEDIUM
Long-Term
17
Short-Term
43

Value

12
P/E-28.30
8
P/B16.10
37
P/S302.09
0
EV/EBITDA-34.09
5

Growth

21
Revenue Growth-79.4%
0
EPS Growth-103.5%
36
FCF Growth-119.4%
31

Momentum

84
12-Month Return78.3%
100
3-Month Return68.9%
100
1-Month Return0.3%
54
RSI (14)74.55
80
50/200 MABullish
75

Profitability

9
ROE-55.4%
41
ROA-37.9%
0
Gross Margin-64.8%
0
Operating Margin-1135.6%
0
Net Margin-1027.3%
0
FCF Yield-3.2%
0

Risk

16
Beta0.25
35
60-Day Volatility119.1%
0

Generated 5/7/2026, 11:38:48 PM · How is this calculated?

QScore Analysis